# FDA Inspection 1122831 - MidSouth Orthopedics - January 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/midsouth-orthopedics/180d2efc-c34e-4a32-a805-2a2b1c1f39e6
Source feed: FDA_Inspections

> FDA Inspection 1122831 for MidSouth Orthopedics on January 14, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122831
- Company Name: MidSouth Orthopedics
- Inspection Date: 2020-01-14
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1007149 - 2017-03-20](https://www.keypedia.com/records/fda_inspections/midsouth-orthopedics/9078570e-1413-4895-a31f-3c3dcd87c797)
- [FDA Inspection 839605 - 2013-07-09](https://www.keypedia.com/records/fda_inspections/midsouth-orthopedics/94cd97ef-0040-4ddf-b07d-96e3423aff87)

Company: https://www.keypedia.com/companies/midsouth-orthopedics/3e283223-9a70-4eab-9ddf-c6eb01f8d8ef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d